Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD

J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2462-2465.e1. doi: 10.1016/j.jaip.2019.03.044. Epub 2019 Apr 4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Allergens / immunology
  • Anti-Inflammatory Agents, Non-Steroidal / immunology
  • Antibodies, Monoclonal, Humanized
  • Asthma, Aspirin-Induced / drug therapy*
  • Asthma, Aspirin-Induced / epidemiology
  • Chronic Disease
  • Comorbidity
  • Drug Hypersensitivity / drug therapy*
  • Drug Hypersensitivity / epidemiology
  • Female
  • France / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Nasal Polyps / drug therapy*
  • Nasal Polyps / epidemiology
  • Rhinitis / drug therapy*
  • Rhinitis / epidemiology

Substances

  • Allergens
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal, Humanized
  • dupilumab

Associated data

  • ClinicalTrials.gov/NCT01920893